Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Li'er Mian Capsules** is an oral traditional Chinese medicine herbal formulation marketed by Chengdu Jiuzhitang Jinding Pharmaceutical for insomnia and related sleep disturbance. The product is described as a Chinese OTC medicine and is supplied as capsules; product listings identify an oral bedtime administration and Chinese drug approval number Z20025186. Its pharmacological mechanism and discrete molecular targets have not been publicly specified; its intended therapeutic rationale is based on traditional Chinese medicine principles, including calming the mind and addressing insomnia associated with heart-kidney disharmony. ([ypk.39.net](https://ypk.39.net/808009/buy/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Li'er Mian Capsules (Chengdu Jiuzhitang Jinding Pharmaceutical).